21
Participants
Start Date
May 31, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
August 31, 2010
LBH581
25 mg/5 ml solution packaged in 6 ml type I glass vials and given as a 30 minutes infusion at the dose of 20 mg/m2 i.v., on day 1 and 8, every 21 days.
Az. San. Ospedaliera Molinette S. Giovanni Battista di Torino, Torino
Istituto Nazionale Ricerca sul Cancro, Genova
Klinikum Kassel Innere Medizin, Kassel
Ospedale Maggiore di Parma, Parma
Klinik für Onkologie und Haematologie, Frankfurt am Main
"Azienda Ospedaliera S. G. Moscati", Avellino
U.O. di Oncologia Medica, Palermo
Azienda Ospedaliera San Camillo Forlanini, Rome
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Southern Europe New Drug Organization
OTHER